782-E Preliminary results of an in progress, first-in-human phase 1 study of Decoy20, an intravenous, killed, multiple immune receptor agonist bacterial product in patients with ad... by Michael J Newman, Jeffery A Nieves, Gary B Gordon, Diana L Hanna, Angela T Alistar, Mohammed NAl Hallak, Roger J Waltzman